RxDoctor Payments Data

Rebecca Nickell, DO

Family Medicine · Highlands Ranch, CONPI 1477516045

Payments from drug & device makers

$7,377in general payments, 2019–2025

Across 363 payments — averaging $20.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • AstraZeneca$759
  • Novo Nordisk$730
  • Amgen$532
  • Lilly USA, LLC$377
  • Pfizer$373
  • plus $3K from 44 others

What the payments were for

  • Food & beverage$7,377100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,377 in reported general payments places this provider in the 95th percentile of 2,079 family medicine providers in Colorado.

See all family medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$444,979
Medicare patients
318
Services billed
6,936

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide48$73,756
MounjaroTirzepatide42$55,953
JardianceEmpagliflozin35$39,604
Trelegy ElliptaFluticasone/Umeclidin/Vilanter37$29,998
EliquisApixaban22$27,604
TrulicityDulaglutide16$22,421
JanuviaSitagliptin Phosphate20$16,711
VascepaIcosapent Ethyl26$9,663
SymbicortBudesonide/Formoterol Fumarate21$6,967
PremarinEstrogens, Conjugated15$5,883
Dexlansoprazole DrDexlansoprazole13$4,849
SynthroidLevothyroxine Sodium36$3,188
Fluticasone-SalmeterolFluticasone Propion/Salmeterol21$3,085
Rosuvastatin Calcium222$2,855
Levothyroxine Sodium366$2,839

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$377$78,37458 claims
Novo NordiskOzempic$730$73,75648 claims
Boehringer IngelheimJardiance$74$39,60435 claims
PfizerEliquis, Premarin$373$33,48737 claims
GSKTrelegy Ellipta$186$29,99837 claims
MerckJanuvia$94$16,71120 claims
AstraZenecaSymbicort$759$6,96721 claims
AbbVieSynthroid$1,417$3,18836 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,079 family medicine providers in Colorado.

Other family medicine in Highlands Ranch

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →